News | Swixx BioPharma | Modern Medicines for All

News

News Archive

• 2023
  • Jan 3, 2023 Swixx and Otsuka Expand Partnership
  • Jan 20, 2023 Swixx and Jazz Pharmaceuticals Expand Partnership in CEE Territories
  • Jan 24, 2023 Swixx and BioCryst Partner in Central and Eastern Europe
  • May 8, 2023 Swixx appoints Marek Vasicek, MD, Chief Operating Officer Russia / Eurasia and R.O.W. (Rest of World) Expansion
  • May 9, 2023 Swixx and BeiGene partner in 13 countries of Central and Eastern Europe, Greece, Cyprus and Malta
  • Jun 27, 2023 Swixx Reveals Refreshed Corporate Visual and Website
• 2022
  • Apr 11, 2022 Swixx Announcement No. 46 Swixx signs deal with Blueprint Medicines Apr 11 2022
  • Apr 19, 2022 Swixx and Jazz Pharmaceuticals Expand Partnership
  • Oct 10, 2022 Swixx and Kyowa Kirin Enter into Partnership for Rare Disease Medicines Portfolio in Poland
  • Dec 19, 2022 Swixx and Kyowa Kirin Expand Partnership for Rare Disease to 13 Countries in Europe
• 2021
  • Feb 5, 2021 Swixx Completed Additional Eleven Business Development Deals in 2021
  • Mar 1, 2021 Swixx Signs Regional Agreement with SeaGen
  • Mar 4, 2021 2021-03-04-Swixx Biopharma Announcment No. 37 - Syndicated Loan Facility
  • Mar 15, 2021 Swixx and Jazz Pharmaceuticals Sign CEE Deal
  • May 20, 2021 Merieux Equity Partners Invests as Swixx raises 45 Million Euros May 20 2021
  • Sep 14, 2021 Pavel Chistyakov Appointed Regional Director Russia CIS Eurasia
  • Oct 4, 2021 Announcement No. 40 - Swixx establishes Greek Affiliate Appoints George Bithas GM October 4 2021
  • Dec 3, 2021 Swixx and Jazz Add Poland in 2nd CEE Deal
  • Dec 13, 2021 Swixx Signs Exclusive Distribution Contract with Sanofi Covering 14 Countries
  • Dec 16, 2021 Swixx Becomes Gilead Partner in Baltic Republics
• 2020
  • Feb 13, 2020 Swixx to represent Norgine in CEE
  • Feb 17, 2020 Swixx Contracts with Alk in West Balkans
  • Mar 25, 2020 Swixx and Vifor Sign a Deal for Slovakia
  • Mar 30, 2020 Swixx signs deal with UPSA for Russia
  • Sep 3, 2020 Swixx and Norgine Sign Distribution Deal for CEE
  • Dec 18, 2020 Swixx and Y-mAbs sign CEE Distribution Deal 18 Dec 2020
• 2019
  • Mar 11, 2019 Amicus Announcement No. 22, 11th Mar 2019
  • May 29, 2019 Amicus Announcement No. 24 - Name Change to Swixx Biopharma 29May2019_
  • Jun 25, 2019 Swixx Announcement No. 25 - DEZSO MARTA APPOINTED COO June 25 2019
• 2018
  • Dec 31, 2018 Amicus Announcement No. 21 - BD Summary 2018
• 2017
  • Apr 15, 2017 Amicus Expands Investor Base - Press Release No 15 April 27 2017
  • Apr 18, 2017 Amicus Press Release No 13 re Cardinal Health April 18 2017
  • Jul 1, 2017 Amicus Press release re BMS Distributorship Agreement - Hungary
  • Jul 20, 2017 Amicus Press release re AFT Licensing Agreement - July 20 2017
  • Aug 21, 2017 Amicus Press Release 17 - Multilac Added to Agreement with Genexo
  • Aug 31, 2017 Andreas Wicki Interview in Nedeljnik Aug 31, 2017
  • Aug 31, 2017 Andreas Wicky Intervju Nedeljnik Avg 31, 2017
  • Nov 1, 2017 Amicus personnel announcement - Istvan Langer
  • Nov 28, 2017 Amicus Announcement No 19 - Norgines Moviprep Signed for Serbia and Macedonia Nov 28 2017
• 2016
  • Feb 2, 2016 Amicus HR Announcmeent Zelenkova 2 Feb 2016
  • Apr 11, 2016 Amicus Announcement GE April 11 2016
  • Jul 19, 2016 Amicus Press release Expanscience July 19 2016
  • Jul 26, 2016 Press release_Cetraxal_Amicus-Salvat FINAL
  • Jul 27, 2016 Amicus Press Release No. 11 -Genexo furazidin July 27 2016
  • Sep 1, 2016 Amicus HR Announcement Marcela Lassakova
  • Oct 14, 2016 Amicus HR Announcement Ivan Pertot
  • Nov 24, 2016 Amicus Press Release No 12 re Grifols Nov 24 2016 Final
• 2015
  • Jun 15, 2015 Press Release APR-Amicus 15.06.15.
  • Jul 17, 2015 Amicus BMS Agreement Press release July 17 2015
  • Oct 12, 2015 Press Release - ALCON
  • Oct 19, 2015 Personnel Announcement - JM Lespinasse CEO Amicus